Back to search
FDAFDA · Food and drugs·Recall number D-1051-2014

HCG (Lyophilized) Stock # 21714, 5000 IUnits-5 mL vial, Compounded by NuVision Pharmacy Dallas, TX 75244

Published February 5, 2014 · Recall initiated: April 15, 2013

Summary

FDA records drug Class I recall D-1051-2014, published February 5, 2014 and initiated April 15, 2013. Recalling firm: NuVision Pharmacy, Inc.; Status: Terminated; Reported quantity: 285 vials; Lot: Lot #s: N06252012@6 Exp 6/25/13; N01042013@15 Exp 1/29/14; N05072012@3 Exp 2/1/15. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
NuVision Pharmacy, Inc.
Distributor
Nationwide
Lot
Lot #s: N06252012@6 Exp 6/25/13; N01042013@15 Exp 1/29/14; N05072012@3 Exp 2/1/15
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was HCG (Lyophilized) Stock # 21714, 5000 IUnits-5 mL vial, Compounded by NuVision Pharmacy Dallas, TX 75244 recalled?

Yes. FDA published recall D-1051-2014 on February 5, 2014. Reported hazard: Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release